for Oct 04, 2022
How does Pseudomonas aeruginosa deal with competitors? Poison. This @mbiojournal study shows that the bacterium releases airborne volatile hydrogen cyanide to inhibit Staphyloccocus aureus growth in low-oxygen in vitro biofilms & in vivo lung environments. https://t.co/FLglpLbP0D pic.twitter.com/GO8QMrSKxH
— ASM (@ASMicrobiology) October 4, 2022
🆕⚡⚡RCT
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) October 4, 2022
Among patients with c. UTI or acute pyelonephritis due GN pathogens cefepime/enmetazobactam, compared with piperacillin/tazobactam, met criteria for noninferiority as well as superiority with respect to clinical cure & microbiological eradicationhttps://t.co/pnaFoZhMky pic.twitter.com/eTXyAQLC2t
Does a Positive MRSA Nasal Screen Predict the Risk for MRSA SSTIS ?
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) October 4, 2022
More supportive data from single-center,retrospective cohort study
📌NPV of 92.0%
(95% CI=87.7%-94.9%)
📌PPV of 70.0%
(95% CI =55.2%-81.7%)
I recently have a pt with (-) nasal (+)tissue cxhttps://t.co/fkrU53p7HI
A Shorter Time to DRESS
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) October 4, 2022
🆕 Small cohort study /single region @CIDJournal @Jamie_L_Waldron suggests significantly shorter latency (4.5d) for beta-lactam induced DRESS than previously thought!
What are the implications for clinical practice?
H/t @_CP_Husseinhttps://t.co/4qAcH7vhHm pic.twitter.com/CGujcBz9eJ
Shameless plug for our study. Similar results. I use it in my practice, but just as another piece of information to be taken into consideration 😉https://t.co/PiWEuVugkd
— Rossana Rosa MD MSc (@DrRossanaRosa) October 4, 2022
Our last contribution on #antibiotic resistance mechanisms of #Escherichia coli following a #onehealth systematic review for assessment of distributions of beta-lactamases in #Latinamerica: https://t.co/Hsa0e6FIoL#science #scicomm #infectiousdiseases #bacteria pic.twitter.com/y0LDPH8M1U
— Daniel Romero-Alvarez (@Vakdaro) October 4, 2022
In vitro activity of tebipenem against ESBL and AmpC producers from @MerinoTrial https://t.co/WUseeLx21W @davidantibiotic @Hendonet @UQMedicine let’s hope there is life in this drug yet with the latest GSK agreement https://t.co/6OJX5DkuxH
— Patrick Harris (@padstamundo) October 4, 2022
Exciting news!!
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) October 4, 2022
Enrollment has begun in an early-stage NIH Supported clinical trial evaluating bacteriophage therapy in adults with cystic fibrosis (CF) colonized with Pseudomonas aeruginosa #IDTwitter #MedEd #TwitteRx https://t.co/2DeNZBpwHY
Data points to rise in #AntibioticResistance in Campylobacter from chicken - the main cause of bacterial food poisoning in the UK https://t.co/wMunysJhq8
— Stop Superbugs (@TheUrgentNeed) October 4, 2022
Are topical antibiotics effective for the management of acute infective conjunctivitis in children?
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) October 4, 2022
A 🆕⚡Randomized Clinical Trial and a Systematic Review and Meta-analysis might provide a definitive answer #IDTwitter #MedEd https://t.co/IfBlrdtx0d pic.twitter.com/0dmb38JCBN
✨Covid-19 & influenza NIH✨
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) October 4, 2022
NIH recommends that hospitalized patients who are suspected of having either influenza or COVID-19 be started on empiric treatment for influenza w oseltamivir as soon as possible and without waiting for influenza test resultshttps://t.co/cG0dtGz3mG
Is that even possible?
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) October 4, 2022
Toxic Megacolon Due to Fulminant Non-antibiotic Associated CDI!
A 40-year-old man presented to the ED with vomiting and diarrhea. He had no known medical history and had not received antimicrobial therapy recently #IDTwitter #MedEd https://t.co/PfutHWzSh1 pic.twitter.com/Vgp9imXHFg
From the soil of pristine wild cranberry bogs, researchers isolated strains of Pseudomonas moorei, a bacterium known for its ability to detoxify pharmaceutical industry environmental contaminants. Learn more in #MRAJournal: https://t.co/1slBFw8j34 pic.twitter.com/z38TlPV7FK
— ASM (@ASMicrobiology) October 4, 2022
We just registered for @CDC_AR's AMR Exchange webinar on health equity through antibiotic stewardship. Will you join us for the conversation? Register here: https://t.co/tXdrzrDvq8 #AntibioticResistance
— Battle Superbugs ☮️ (@battlesuperbugs) October 4, 2022
Join our team @mgh_ast @mgh_id. We’re hiring a Clinical Pharmacist - Infectious Diseases to join our growing ASP team. And you get to work with @CLiPharmD @GramPosiTiff @HIV_PharmD and @ARLetourneau! #TwitterRx https://t.co/nRIY9zaFX2
— MGH Antimicrobial Stewardship Team (@mgh_ast) October 4, 2022
Meet Dan Landry (@DanLandryRX) 👋
— QID | Pharmacist Network (@QIDnetwork) October 4, 2022
He is currently an #InfectiousDiseases/antimicrobial stewardship #pharmacist at the Dr-Georges-L.-Dumont University Hospital Centre in Moncton, New Brunswick!
Learn more about him in his #influenza event on QID: https://t.co/EqLs3SaKhq pic.twitter.com/HJfiLZDABn
Coming up: Don’t miss @pewhealth’s David Hyun on @CDCgov’s AMR Exchange webinar. Register for the Oct. 25 event below. #healthequity #antibioticstewardship https://t.co/VZu6gY3Wyr pic.twitter.com/pXUNhi9q5V
— Save Antibiotics (@saveantibiotics) October 4, 2022
Identification of broad anti- #coronavirus chemical agents for repurposing against #SARSCoV2 and variants of concernhttps://t.co/PrQ9YOmPQ7 #OpenAccess #COVID19 pic.twitter.com/upJFc7bpiP
— MicrobesInfect (@MicrobesInfect) October 4, 2022
Severe Manifestations of Monkeypox among People who are Immunocompromised Due to HIV or Other Conditions. Worth reading this @CDCgov alert. PWH with⬇️CD4 counts and not on ARV are at risk of severe MPX. https://t.co/Wb7NRl9xwx
— Carlos del Rio (@CarlosdelRio7) October 4, 2022
Quantifying Environmental Mitigation of Aerosol Viral Load in a Controlled Chamber With Participants Diagnosed With Coronavirus Disease 2019
— Long Covid Patient Action Group UK (@LC_UK_Action) October 4, 2022
Clinical Infectious Diseases, Volume 75, Issue 1, 1 July 2022, Pages e174–e184,https://t.co/Ph5cXZXTQF
Errors in perioperative antimicrobial use for hospitalized surgical patients https://t.co/sCnxAV7SCW
— PROA_HUCA-HMN (@HucaProa) October 4, 2022
Nonprofit tied to Wuhan lab gets $650K more to study coronaviruses
— David Cranmer Underdown (@DavidCranmerUn1) October 4, 2022
A $653,392 grant to Peter Daszak’s EcoHealth Alliance, awarded Sept. 21, is being administered by the National Institute of Allergy and Infectious Diseases — whose director, https://t.co/Bla68rLqRq
“This is a pandemic which has the potential to be more deadly than #COVID19,” @UKAMREnvoy warns of #antibioticresistance. https://t.co/rxpi7QA5Z2
— Save Antibiotics (@saveantibiotics) October 4, 2022
Genomic analysis of #Elizabethkingia species from aquatic environments:
— MicrobesInfect (@MicrobesInfect) October 4, 2022
Evidence for potential clinical transmissionhttps://t.co/nLBZlhfA51 #OpenAccess pic.twitter.com/DP29uXbHVp
The 2022 #NFID Annual Influenza/Pneumococcal Disease News Conference is officially underway. Learn more and find additional resources to help #FightFlu this season: https://t.co/knRjMvKZi0 pic.twitter.com/W1UlrhtO1S
— NFID (@NFIDvaccines) October 4, 2022
#NFID CEO Marla Dalton, CAE #LeadingByExample and getting #vaccinated against both #flu and #COVID-19 during the same visit https://t.co/O98LUitlMx #FightFlu #GetVaccinated #StopTheSpread pic.twitter.com/ajRSRwucrf
— NFID (@NFIDvaccines) October 4, 2022
PRO/AMR> Antimicrobial stewardship (110): Viet Nam, CA-RTI, clinical outcome https://t.co/qpLOHQ1TTJ
— ProMED (@ProMED_mail) October 4, 2022
PRO/AMR> Antimicrobial stewardship (110): cross-country, human AB use in animal, LMICs https://t.co/wj4YIo3RKV
— ProMED (@ProMED_mail) October 4, 2022
Infectious Diseases-Related Hospitalizations During Oral Polio Vaccine (OPV) and Non-OPV Immunization Periods: An Empirical Evaluation of all Hospital Discharges in California (1985–2010)
— Clinical Infectious Diseases (@CIDJournal) October 4, 2022
🔗 https://t.co/7ow31vswOH pic.twitter.com/Rpidlo6Kyg
New Analysis Shows Micronutrient Deficiency On Admission To Hospital For COVID-19 Related To High Risk Of ICU Admission & Death https://t.co/kUmKmf8qJ3 #coronavirus #infectiousdiseases #micronutrients #vitamindeficiency
— Dr. Rath Foundation (@rathfoundation) October 4, 2022
Mycobacterium avium complex (MAC) is a group of bacteria related to tuberculosis that can make people with weaker immune systems very sick. Now @ljiresearch researchers uncovered a defect that stops T cells from fighting MAC. Read more: https://t.co/FWTHDYaR5P pic.twitter.com/E9Lu2AXWi6
— Genetic Engineering & Biotechnology News (@GENbio) October 4, 2022
The latest The antimicrobial stewardship Daily! https://t.co/G3kkN9iU3i Thanks to @saveantibiotics @Triscribe @jac_amr #publichealth #healthforall
— Abid Hussain (@MicrobLog_me_uk) October 4, 2022
Most people who get #COVID19 fully recover, but some go on to develop #LongCovid. Pediatric infectious diseases specialist @CR_OliveiraJr explains long COVID symptoms and treatments. @UNICEF https://t.co/eXyGa4mB7p
— Dirk Holzinger (@DirkHolzinger) October 4, 2022
More studies are key to understand the complexities of how infectious diseases can impact global health. The findings of this study shed light on the importance of prevention & how it can guide decision-making. @IndianExpress https://t.co/Qlo6B1Is2g
— Dr Monique Eloit (@WOAH_DG) October 4, 2022
Utilising cumulative antibiogram data to enhance antibiotic stewardship capacity in the Cape Coast Teaching Hospital, Ghana https://t.co/neBV2qj7R5
— AntibioticResistance (@AntibioticResis) October 4, 2022
✨Covid-19 & influenza NIH✨
— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) October 4, 2022
Clinicians should consider deferring influenza vaccination for symptomatic patients with COVID-19 until these patients are no longer moderately or severely ill and have completed their COVID-19 isolation period. #IDTwitter https://t.co/cG0dtGz3mG
Referenced extensively is Dr. Bradley's piece from mid-August: Women in #epidemiology #infectionprevention #stewardshiphttps://t.co/4suPWkN5fT
— ASHE Journal (@ASHE_Journal) October 4, 2022
A new study published in Microbiology Spectrum demonstrates positive preclinical results on the safety and efficacy of a potential #RNAvaccine against #Zika virus using #CyTOF for #immuneprofiling. @GENbio https://t.co/RQYUnbDgIT
— Standard BioTools (@Standard_BioT) October 4, 2022
Tracking the circulation of infectious diseases through wastewater is not new, but it’s becoming vital in the hunt for the next version of #COVID19. Scientists have warned the next variant could be far more deadly than #omicron: https://t.co/FFwUQpLH2H
— Gavi, the Vaccine Alliance (@gavi) October 4, 2022
Ceftolozane/tazobactam for the treatment of bacteremia: a systematic literature review (SLR) https://t.co/TDCHHGnLbA
— AntibioticResistance (@AntibioticResis) October 4, 2022
Mentioned towards the end, some perspective from @dr_pbailey on the piece co-written with @julie_justo and @PriyaNori: Restricted reproductive health and infectious diseases outcomes: A call to action https://t.co/tRipdkqFlF
— ASHE Journal (@ASHE_Journal) October 4, 2022
NIH-Supported Clinical Trial of Phage Therapy for Cystic Fibrosis Begins | NIH: National Institute of Allergy and Infectious Diseases https://t.co/eAjqHHEdoo
— Michael Z. David, MD, PhD🧪🩻💉🔬🧬 (@michael_david1) October 4, 2022
NTD spoke with the founder and CEO of https://t.co/vdwrNb7A31, Adam Andrzejewski, to learn more about the financial information tied to the director of the National Institute of Allergy and Infectious Diseases, Dr. #AnthonyFauci.
— NTD News (@news_ntd) October 4, 2022
Watch full video 👉https://t.co/tbE3x6aCVd pic.twitter.com/RruTY9hmY0
Trends and Correlation Between Antimicrobial Resistance and Antibiotics Consumption in a Specialist Children's Hospital from 2016 to 2021 https://t.co/LR9bTP6S0N
— AntibioticResistance (@AntibioticResis) October 4, 2022
@MandyLau1668663 talking about the work she is doing as part of her @MRCNIHRTMRP PhD aiming to improve the analysis of microbiological outcomes in trials of antimicrobial stewardship interventions @CTRCardiffUni @ictmc2022 #ICTMC2022 pic.twitter.com/XnypSmjagm
— Dave Gillespie (he/him) (@DaveGuk87) October 4, 2022
Time to appropriate antimicrobial therapy serves an independent prognostic indicator in children with nosocomial Klebsiella pneumoniae bloodstream infection https://t.co/cJu9QfJCy8
— Tristan Timbrook (@TristanTimbrook) October 4, 2022
NEWS SCAN: Topical antibiotics for conjunctivitis; H3N2 #flu still dominant; More #AvianFlu in US poultry; BARDA monoclonal antibody contracthttps://t.co/7q3rNAOvmz#AMR #AntibioticStewardship #Influenza
— CIDRAP (@CIDRAP) October 4, 2022
Really useful - thanks - supports conclusions of our survey across Europe - ‘The main barriers to implement OPAT/infusion services were lack of organisational structure or guidelines’ https://t.co/vyRC045daL
— Mark Gilchrist (@MGilchrist123) October 4, 2022
Antibacterial Effect of Moringa (Moringa oleifera) Leaf Ethanolic Extract Against Staphylococcus aureus and Escherichia coli https://t.co/V3OlCdbjbm
— AntibioticResistance (@AntibioticResis) October 4, 2022
The Norton Healthcare electronic antimicrobial stewardship program: An opt-out approach to antimicrobial stewardship https://t.co/KKvhcgQ4KU pic.twitter.com/rkhuikL9PB
— ASP_Papers (@ASP_Papers) October 4, 2022
@OSUGlobal @OSUWexMed @osu_pharmacy #AMS #antibiotic stewardship team in #Kenya hospitals discussing collaboration The 🌎 is one @IDSAInfo @CDCGlobal @SIDPharm @accpinfdprn @PedsPharmD @TheBack140 pic.twitter.com/nwkTanl8z9
— Debbie Goff (@idpharmd) October 4, 2022
Advances in therapeutic #nanodrug delivery systems for infectious lung diseases: a review an article on #ScienceOpen https://t.co/sF7T21TY6M
— Acta Materia Medica (@AMM_journal) October 4, 2022
This is an article from 10 yrs ago
— Dr Christine Peters (@microlabdoc) October 4, 2022
“Threats such as “those of you with mortgages and career aspirations had better be afraid” left staff with little faith that the organisation would handle fairly any concern that they might have”
What’s changed? https://t.co/9bU3itJkXE
With extreme pressures on hospitals, it's an ongoing challenge to free up beds and reduce the length of time patients need to spend in them. Great segment on the #OPAT service on @STVNews featuring @raseaton66: https://t.co/C6FYDFJfwr
— BSAC (@BSACandJAC) October 4, 2022
Created by Cameron Forbes. Last updated October 05, 2022 at 05:16 EST.